David Shook's most recent trade in Lyell Immunopharma Inc was a trade of 1,977 Common Stock done at an average price of $12.6 . Disclosure was reported to the exchange on June 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyell Immunopharma Inc | David R. Shook | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.64 per share. | 10 Jun 2026 | 1,977 | 20,923 | - | 12.6 | 24,989 | Common Stock |
| Lyell Immunopharma Inc | David R. Shook | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 50,000 | 50,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | David R. Shook | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 43,750 | 43,750 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | David R. Shook | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 21,900 | 21,900 | - | 0 | Common Stock | |
| Nkarta Inc | David R. Shook | See Remarks | 15 Jan 2025 | 8,638 | 190,955 | - | 2.2 | 19,004 | Common Stock | |
| Nkarta Inc | David R. Shook | See Remarks | 03 Jan 2025 | 117,500 | 117,500 | - | - | Stock Option (right to buy) | ||
| Nkarta Inc | David R. Shook | See Remarks | 03 Jan 2025 | 59,000 | 199,593 | - | 0 | Common Stock | ||
| Nkarta Inc | David R. Shook | See Remarks | 21 Aug 2024 | 1,352 | 138,593 | - | 5.1 | 6,909 | Common Stock | |
| Nkarta Inc | David R. Shook | See Remarks | 15 Jul 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | ||
| Nkarta Inc | David R. Shook | See Remarks | 15 Jul 2024 | 23,421 | 139,945 | - | 0 | Common Stock | ||
| Nkarta Inc | David Shook | Chief Medical Officer | 18 Jun 2024 | 456 | 116,524 | - | 5.6 | 2,554 | Common Stock | |
| Nkarta Inc | David Shook | Chief Medical Officer | 16 Jan 2024 | 3,552 | 114,980 | - | 8.7 | 31,044 | Common Stock | |
| Nkarta Inc | Shook David | Chief Medical Officer | 04 Jan 2024 | 112,500 | 112,500 | - | - | Stock Option (right to buy) | ||
| Nkarta Inc | David Shook | Chief Medical Officer | 04 Jan 2024 | 56,000 | 118,532 | - | 0 | Common Stock | ||
| Nkarta Inc | David Shook | Chief Medical Officer | 21 Aug 2023 | 1,331 | 60,532 | - | 1.8 | 2,436 | Common Stock | |
| Nkarta Inc | David Shook | Chief Medical Officer | 01 Jul 2023 | 208,000 | 208,000 | - | - | Stock Option (right to buy) | ||
| Nkarta Inc | David Shook | Chief Medical Officer | 20 Jun 2023 | 439 | 61,863 | - | 4.8 | 2,129 | Common Stock | |
| Nkarta Inc | David Shook | Chief Medical Officer | 13 Jan 2023 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | ||
| Nkarta Inc | David Shook | Chief Medical Officer | 13 Jan 2023 | 37,500 | 60,477 | - | 0 | Common Stock | ||
| Nkarta Inc | David Shook | Chief Medical Officer | 13 Jan 2023 | 175 | 60,302 | - | 5.5 | 961 | Common Stock |